Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 40,133 | 42,624 | 49,990 | 80,179 | 53,273 |
| Gross Profit | 40,133 | 42,624 | 49,990 | 80,179 | 53,273 |
| Operating Expenses | 97,315 | 160,477 | 128,968 | 130,992 | 99,375 |
| Operating Income | -57,182 | -117,853 | -78,978 | -50,813 | -46,102 |
| Interest Expense | 20,313 | 22,592 | 18,680 | 16,562 | 15,248 |
| Other Income | 5,094 | -2,058 | 2,662 | -4,867 | -12,482 |
| Pre-tax Income | -72,401 | -142,503 | -94,996 | -72,242 | -73,832 |
| Net Income Continuous | -72,401 | -142,503 | -94,996 | -72,242 | -73,832 |
| Net Income | $-72,401 | $-142,503 | $-94,996 | $-72,242 | $-73,832 |
| EPS Basic Total Ops | -1.15 | -2.52 | -1.73 | -1.35 | -1.70 |
| EPS Basic Continuous Ops | -1.15 | -2.52 | -1.71 | -1.33 | -1.67 |
| EPS Diluted Total Ops | -1.15 | -2.52 | -1.73 | -1.35 | -1.70 |
| EPS Diluted Continuous Ops | -1.15 | -2.52 | -1.71 | -1.33 | -1.67 |
| EBITDA(a) | $-46,194 | $-105,683 | $-66,725 | $-41,389 | $-39,135 |